Bipolar Disorder Therapy in a 26-Year-Old Female Patient Case Study

Exclusively available on Available only on IvyPanda®
This academic paper example has been carefully picked, checked and refined by our editorial team.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment

This case study describes a 26-year-old woman of Korean descent who was diagnosed with bipolar I disorder. Generally, bipolar disorder is a rather severe medical condition that is characterized by unusual shifts in concentration, activity levels, energy, and mood, as well as reduced ability to carry out everyday tasks (Carvalho et al., 2020). Particularly bipolar I disorder is “defined by manic episodes that last at least seven days, or by manic symptoms that are so severe that the person needs immediate hospital care” (National Institute of Mental Health [NIMH], 2020, para. 3). Depressive episodes that may last more than two weeks can also be present (Carvalho et al., 2020).

This mental disorder is typically treated with medications that may help manage symptoms. For example, treatment plans can include mood stabilizers (such as Lithobid), antipsychotics (namely, Zyprexa), and antidepressants (NIMH, 2020). To prevent triggering a manic episode, antidepressants and mood stabilizers should be combined.

There was a twenty-one-day hospitalization for the onset of acute mania. The patient’s physician reported her to be in overall good health, and lab studies were all within normal limits. During her hospitalization, there was genetic testing that revealed the woman being positive for the CYP2D6*10 allele, which negatively affects the metabolism of a number of drugs, namely mood stabilizers, antipsychotics, and antidepressants.

According to Tirona and Kim (2017), in Asians, CYP2D6∗10 that is characterized by nonsynonymous polymorphism and decreased activity is found in up to 50%. The woman confessed that she stopped taking her lithium that was prescribed in the hospital. The patient denies having auditory or visual hallucinations, and there are no signs of delusional or paranoid thought processes. What is more, the woman denies suicidal or homicidal ideation as well, though her Young Mania Rating Scale (YMRS) score is 22, which is mild mania.

The first decision step was to begin Risperdal 1mg orally twice a day. Researchers note that it is “indicated for the treatment of acute manic or mixed episodes associated with bipolar I disorder” (“Risperdal,” 2020, para. 4). Even though it is metabolized by CYP2D6, it was decided to avoid prescribing other medications and monitor the effectiveness and side effects of this drug (“Risperdal,” 2020). What is more, since it was impossible to rely on the patient and trust her about taking medicine properly after the lithium incident, prescribing only one drug and explaining the necessity of taking it was important.

The second decision point came after the patient returned to the office after four weeks. She was accompanied by her mother, who had to help her enter the office. The client looked very sedated and lethargic, and it was reported by the mother that the patient had been in this state since approximately a week after the last office visit. It was decided to decrease Risperdal to 1mg at HS. This decision was based on the necessity to avoid toxicity because it was evident that there was a problem with this drug metabolism.

In four weeks, the client returns to the office with several improvements. It becomes evident that she was compliant with the prescription, and now she appears to be less sedated and lethargic, which is the result of lowering the levels of Risperdal in her blood. What is more, her Young Mania Rating Scale has decreased from 22 to 16, which is a bit more than a 25% decrease in symptoms. Therefore, the third decision step is to continue at the same dose of Risperdal (1mg at bedtime) and reassess in four weeks. During this period, the patient is expected to get used to taking drugs and show an improvement in her mental state. After that, it may become possible to prescribe other medications and be sure that the woman will not avoid taking them.

References

Carvalho, A. F., Firth, J., & Vieta, E. (2020). Bipolar disorder. New England Journal of Medicine, 383(1), 58-66.

National Institute of Mental Health [NIMH]. (2020). Bipolar disorder. NIMH. Web.

Risperdal. (2020). RxList. Web.

Tirona, R. G., & Kim, R. B. (2017). Introduction to clinical pharmacology. In D. Robertson & G. H. Williams (Eds.), Clinical and translational science (2nd ed, pp. 365-388). Elsevier.

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2022, May 19). Bipolar Disorder Therapy in a 26-Year-Old Female Patient. https://ivypanda.com/essays/bipolar-disorder-therapy-case-study/

Work Cited

"Bipolar Disorder Therapy in a 26-Year-Old Female Patient." IvyPanda, 19 May 2022, ivypanda.com/essays/bipolar-disorder-therapy-case-study/.

References

IvyPanda. (2022) 'Bipolar Disorder Therapy in a 26-Year-Old Female Patient'. 19 May.

References

IvyPanda. 2022. "Bipolar Disorder Therapy in a 26-Year-Old Female Patient." May 19, 2022. https://ivypanda.com/essays/bipolar-disorder-therapy-case-study/.

1. IvyPanda. "Bipolar Disorder Therapy in a 26-Year-Old Female Patient." May 19, 2022. https://ivypanda.com/essays/bipolar-disorder-therapy-case-study/.


Bibliography


IvyPanda. "Bipolar Disorder Therapy in a 26-Year-Old Female Patient." May 19, 2022. https://ivypanda.com/essays/bipolar-disorder-therapy-case-study/.

If, for any reason, you believe that this content should not be published on our website, please request its removal.
Updated:
Privacy Settings

IvyPanda uses cookies and similar technologies to enhance your experience, enabling functionalities such as:

  • Basic site functions
  • Ensuring secure, safe transactions
  • Secure account login
  • Remembering account, browser, and regional preferences
  • Remembering privacy and security settings
  • Analyzing site traffic and usage
  • Personalized search, content, and recommendations
  • Displaying relevant, targeted ads on and off IvyPanda

Please refer to IvyPanda's Cookies Policy and Privacy Policy for detailed information.

Required Cookies & Technologies
Always active

Certain technologies we use are essential for critical functions such as security and site integrity, account authentication, security and privacy preferences, internal site usage and maintenance data, and ensuring the site operates correctly for browsing and transactions.

Site Customization

Cookies and similar technologies are used to enhance your experience by:

  • Remembering general and regional preferences
  • Personalizing content, search, recommendations, and offers

Some functions, such as personalized recommendations, account preferences, or localization, may not work correctly without these technologies. For more details, please refer to IvyPanda's Cookies Policy.

Personalized Advertising

To enable personalized advertising (such as interest-based ads), we may share your data with our marketing and advertising partners using cookies and other technologies. These partners may have their own information collected about you. Turning off the personalized advertising setting won't stop you from seeing IvyPanda ads, but it may make the ads you see less relevant or more repetitive.

Personalized advertising may be considered a "sale" or "sharing" of the information under California and other state privacy laws, and you may have the right to opt out. Turning off personalized advertising allows you to exercise your right to opt out. Learn more in IvyPanda's Cookies Policy and Privacy Policy.

1 / 1